{
  "paper_id": "2b84b189357f940efd105bcfe6e45ea14bdcc95c",
  "metadata": {
    "title": "Armed Forces Health Surveillance Center (AFHSC) and Cherokee Nation Technology Solutions",
    "coda_data_split": "test",
    "coda_paper_id": 850,
    "coda_has_expert_labels": false,
    "subset": "comm_use_subset"
  },
  "abstract": [
    {
      "original_text": "Background: Population-based serologic studies are a vital tool for understanding the epidemiology of influenza and other respiratory viruses, including the early assessment of the transmissibility and severity of the 2009 influenza pandemic, and Middle",
      "sentences": [
        [
          {
            "segment_text": "Background : Population-based serologic studies are a vital tool for understanding the epidemiology of influenza and other respiratory viruses ,",
            "crowd_label": "background"
          },
          {
            "segment_text": "including the early assessment of the transmissibility and severity of the 2009 influenza pandemic , and Middle",
            "crowd_label": "background"
          }
        ]
      ]
    },
    {
      "original_text": "East respiratory syndrome coronavirus. However, interpretation of the results of serologic studies has been hampered by the diversity of approaches and the lack of standardized methods and reporting.",
      "sentences": [
        [
          {
            "segment_text": "East respiratory syndrome coronavirus .",
            "crowd_label": "background"
          }
        ],
        [
          {
            "segment_text": "However , interpretation of the results of serologic studies has been hampered by the diversity of approaches and the lack of standardized methods and reporting .",
            "crowd_label": "background"
          }
        ]
      ]
    },
    {
      "original_text": "Objective: The objective of the CONSISE ROSES-I statement was to improve the quality and transparency of reporting of influenza seroepidemiologic studies and facilitate the assessment of the validity and generalizability of published results.",
      "sentences": [
        [
          {
            "segment_text": "Objective : The objective of the CONSISE ROSES-I statement was to improve the quality and transparency of reporting of influenza seroepidemiologic studies and facilitate the assessment of the validity and generalizability of published results .",
            "crowd_label": "purpose"
          }
        ]
      ]
    },
    {
      "original_text": "The ROSES-I statement was developed as an expert consensus of the CON-SISE epidemiology and laboratory working groups. The recommendations are presented in the familiar format of a reporting guideline. Because seroepidemiologic studies are a specific type of observational epidemiology study, the ROSES-I statement is built upon the STROBE guidelines. As such, the ROSES-I statement should be seen as an extension of the STROBE guidelines.",
      "sentences": [
        [
          {
            "segment_text": "The ROSES-I statement was developed as an expert consensus of the CON-SISE epidemiology and laboratory working groups .",
            "crowd_label": "purpose"
          }
        ],
        [
          {
            "segment_text": "The recommendations are presented in the familiar format of a reporting guideline .",
            "crowd_label": "finding"
          }
        ],
        [
          {
            "segment_text": "Because seroepidemiologic studies are a specific type of observational epidemiology study ,",
            "crowd_label": "finding"
          },
          {
            "segment_text": "the ROSES-I statement is built upon the STROBE guidelines .",
            "crowd_label": "finding"
          }
        ],
        [
          {
            "segment_text": "As such , the ROSES-I statement should be seen as an extension of the STROBE guidelines .",
            "crowd_label": "finding"
          }
        ]
      ]
    },
    {
      "original_text": "The ROSES-I statement presents 42 items that can be used as a checklist of the information that should be included in the results of published seroepidemiologic studies, and which can also serve as a guide to the items that need to be considered during study design and implementation.",
      "sentences": [
        [
          {
            "segment_text": "The ROSES-I statement presents 42 items that can be used as a checklist of the information that should be included in the results of published seroepidemiologic studies ,",
            "crowd_label": "finding"
          },
          {
            "segment_text": "and which can also serve as a guide to the items that need to be considered during study design and implementation .",
            "crowd_label": "finding"
          }
        ]
      ]
    },
    {
      "original_text": "We hope that the ROSES-I statement will contribute to improving the quality of reporting of seroepidemiologic studies. on behalf of the CONSISE Steering Committee*",
      "sentences": [
        [
          {
            "segment_text": "We hope that the ROSES-I statement will contribute to improving the quality of reporting of seroepidemiologic studies .",
            "crowd_label": "finding"
          }
        ],
        [
          {
            "segment_text": "on behalf of the CONSISE Steering Committee *",
            "crowd_label": "finding"
          }
        ]
      ]
    },
    {
      "original_text": "For all pathogens, cases of symptomatic illness from infections that are detected through routine healthcare statistics, laboratory networks, or other surveillance and reporting systems are only a small proportion of infections affecting a population. Relying on case incidence detected by this information alone can lead to large underestimates of infection rates and overestimates of severity of illness among the general population. 1 Prior to, or during the early stages of epidemics, serologic testing of affected populations can provide valuable information on the proportion of the population that have a low titer of cross-reactive *CONSISE Steering Committee members are listed in Appendix 1. ‡Retired.",
      "sentences": [
        [
          {
            "segment_text": "For all pathogens , cases of symptomatic illness from infections that are detected through routine healthcare statistics ,",
            "crowd_label": "finding"
          },
          {
            "segment_text": "laboratory networks , or other surveillance and reporting systems are only a small proportion of infections affecting a population .",
            "crowd_label": "finding"
          }
        ],
        [
          {
            "segment_text": "Relying on case incidence detected by this information alone can lead to large underestimates of infection rates and overestimates of severity of illness among the general population .",
            "crowd_label": "finding"
          }
        ],
        [
          {
            "segment_text": "1 Prior to , or during the early stages of epidemics ,",
            "crowd_label": "finding"
          },
          {
            "segment_text": "serologic testing of affected populations can provide valuable information on the proportion of the population that have a low titer of cross-reactive * CONSISE Steering Committee members are listed in Appendix 1 .",
            "crowd_label": "finding"
          }
        ],
        [
          {
            "segment_text": "‡ Retired .",
            "crowd_label": "other"
          }
        ]
      ]
    }
  ],
  "abstract_stats": {
    "paragraph_num": "7",
    "sentence_num": "15",
    "segment_num": "20",
    "token_num": "363"
  }
}